The addition of adalimumab to methotrexate reduces rheumatoid arthritis activity in patients with longstanding disease

Clin Exp Rheumatol. 2004 Mar-Apr;22(2):144.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Rheumatoid / drug therapy*
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Humans
  • Methotrexate / administration & dosage*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Adalimumab
  • Methotrexate